HIGHLIGHTS
- who: Francesco Franchi from the Division of Cardiology, University of Florida College Jacksonville, FL, USA have published the research: Pharmacokinetic and pharmacodynamic profiles of a novel phospholipid-aspirin complex liquid formulation and low dose enteric-coated aspirin: results from a prospective, randomized, crossover study, in the Journal: (JOURNAL) of April/29,/2021
- what: This study assessed the PK (absorption and distribution) and PD (antiplatelet) profiles of an 81 mg dose of the approved PL-ASA formulation, with comparison to EC-ASA. Since the study was an exploratory study without any hypothesis testing, no adjustments were . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.